Introduction
Serotonin (5-HT), a major component of the inflammatory chemical milieu, is released from platelets, mast cells, or basophils that infiltrate an area of tissue damage [1] . Once released, 5-HT is free to interact with a number of molecularly distinct receptor subtypes, including the 5-HT 3 receptor expressed in primary afferent nociceptors [2, 3] , and is capable of evoking pain and hyperalgesia [4] . To date, receptors for 5-HT can be classified into seven types and can be further distinguished into at least 13 subtypes. Unlike all other known 5-HT receptor subtypes, which are G-protein coupled, the 5-HT 3 receptor is a member of the excitatory ligand-gated ion channel (LGIC) superfamily [5, 6] . Researchers believe that 5-HT 3 receptors located on sensory nerve terminals are mainly responsible for 5-HT-induced pain and hyperalgesia, although other subtypes of 5-HT receptors are also involved [4, [7] [8] [9] [10] . Recently we have demonstrated the potentiation of 5-HT 3 receptor function by substance P and α-methyl-5-HT, an agonist of 5-HT 2 receptor, through a protein kinase C (PKC)-dependent pathway in primary sensory neurons [11, 12] . Bradykinin (BK) is an inflammatory mediator that plays a pivotal role in pain and hyperalgesia by exciting nociceptors and sensitizing them through activation of PKC [13] . BK responses are mediated by BK receptors. There are two main types of BK receptors, B 1 and B 2 . B 2 BK receptors are constitutively and abundantly expressed in primary sensory neu-
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rons [14] . The B 2 BK receptor has been implicated in BKinduced nociceptor activities and nociceptive behaviors [15] [16] [17] , and animals deficient in B 2 BK receptors show hypoalgesia and reduced inflammatory responses [18, 19] . The cDNA of the B 2 BK receptor has already been cloned [20] and evidence for the contribution of the PKC pathway to the B 2 BK receptormediated algesic action of BK has accumulated [17, 21] . Thus, it is highly possible that 5-HT 3 receptor function is also enhanced by BK through a PKC-dependent pathway. The present study aimed to explore whether the modulation of BK in 5-HT 3 receptor-mediated current could occur in trigeminal ganglion (TG) neurons. Electrophysiological recordings Whole-cell patch-clamp recordings were carried out at room temperature (22-24 ºC) using a whole-cell patch-clamp amplifier (CEZ-2400, Nihon Kohden, Tokyo, Japan). Pipettes were filled with internal solution containing (in mmol/L): KCl 140, CaCl 2 1, MgCl 2 2.5, HEPES 10, egtazic acid 11, and ATP 5; the pH was adjusted to 7.2 with KOH and the osmolarity was adjusted to 310 mOsm/L with sucrose. Cells were bathed in an external solution containing (in mmol/L): NaCl 150, KCl 5, CaCl 2 2.5, MgCl 2 2, HEPES 10, and D-glucose 10; the osmolarity was adjusted to 340 mOsm/L with sucrose and the pH was adjusted to 7.4 with NaOH. The resistance of the recording pipette was in the range of 2-5 MΩ. A small patch of membrane underneath the tip of the pipette was aspirated to form a gigaseal and then more negative pressure was applied to rupture it, thus establishing a whole-cell configuration. The adjustment of capacitance compensation and series resistance compensation was done before recording the membrane currents. The holding potential was set at -60 mV, unless otherwise indicated. Membrane currents were filtered at 10 kHz (-3 dB), and the data were stored and analyzed in a computer with data acquisition software and hardware systems (Huazhong University of Science and Technology, Wuhan, China) and recorded using a pen recorder (Nihon Kohden).
Materials and methods

Isolation of TG neurons
Drug application Drugs used in the experiments included: serotonin hydrochloride (5-HT, Sigma), bradykinin (BK, Sigma), 2-methyl-5-hydroxytryptamine maleate (Research Biochemicals Incorporated, Natick, MA, USA), ICS -205,930 (Research Biochemicals Incorporated), Hoe 140 (Sigma), and GF 109203X (Research Biochemicals Incorporated). All drugs except GF 109203X were dissolved in the external solution just prior to use and held in a linear array of fused silica tubes (od/id=500/200 µm) connected to a series of independent reservoirs. The distance from the tube mouth to the cell examined was approximately 100 µm. The application of each drug was driven by gravity and controlled by the corresponding valve, and rapid solution exchange could be achieved by shifting the tubes horizontally with a micromanipulator. Cells were constantly bathed in normal external solution flowing from one tube connected to a larger reservoir between drug applications. In a number of the experiments GF 109203X needed to be applied intracellularly and was dissolved in the internal solution.
Data analysis Data were statistically analyzed using Student's t-test or analysis of variance (ANOVA). Statistical analysis of the concentration-response data was carried out using the non-linear, curve-fitting program ALLFIT. Current values were expressed as mean±SEM.
Results
Current mediated by the 5-HT 3 receptor in rat TG neurons In our experiments neurons freshly isolated from rat TG were round or elliptic in shape under light microscopy. The majority of the cells examined responded to 5-HT applied externally with a concentration (1×10 When 5-HT was applied regularly for 3-s durations with 3-min intervals, the I 5-HT was repeated stably within at least 90 min, and the change in amplitude was within 8% (data not shown). Thus, we used this pattern of 5-HT applications in the following experiments.
Potentiation of I 5-HT by pre-application of BK BK applied for 30 s prior to the application of 5-HT (1×10 -4 mol/L) potentiated I 5-HT reversibly in the majority of the neurons examined (66/74, 89.2%). In 18 of the 74 (24.3%) cells sensitive to 5-HT there was also a response to BK with a very small inward or outward current (<150 pA), which showed slow desensitization (data not shown). The BK potentiation of I 5-HT was observed irrespective of whether BK evoked an inward or outward current, or no response. The I 5-HT was potentiated by the pre-application of BK (1×10 -6 -1×10 -10 mol/L) in a concentration-dependent manner. Figure  1B shows that with an increase in BK concentration from 1×10 -10 to 1×10 -6 mol/L, the amplitude of I 5-HT (1×10 -4 mol/L) increased stepwise until it reached its maximum at a concentration of 1×10 -7 mol/L BK (71.6±4.9%). Thereafter this potentiating effect did not increase further, but rather decayed with further increases in BK concentration until 10 -6 mol/L ( Figure 1B) .
Effect of the duration of BK pre-application on I 5-HT To explore the relationship between the effect of BK on I 5-HT and the duration of the pre-application of BK, different BK preapplication durations ranging from 15 to 120 s were tested. Figure 1C illustrates that the amplitude of 5-HT alone at a holding potential of -60 mV when I-V curves were drawn ( Figure 3B ). The reverse potential values for the two curves were essentially the same at 0 mV. The amplitude of I 5-HT with BK pre-application was greater than that without BK pre-application at all holding potentials from -80 to +40 mV, and the BK-induced alteration of I 5-HT did not correlate with the change in holding potential (ANOVA; P>0.05, n=8), which suggests that the potentiation of I 5-HT by BK occurs in a voltage-independent manner and the reverse potential of I 5-HT is unchanged by BK. Intracellular signal transduction mechanism underlying BK potentiation of I 5-HT To explore whether this enhancing effect is mediated through BK-receptor-induced intracellular signal transduction, for example, activating PKC, GF-109203X, a selective PKC inhibitor [22] , was included in the recording pipette for intracellular dialysis using the re-patch technique. In the control experiment with the pipette filled with normal internal solution, the BK-induced potentiation of I 5-HT was 72.2%±5.2%. In contrast, when using a pipette filled with GF-109203X (2 µmol/L) containing internal solution the BK-induced potentiation of I 5-HT was 13.5%±4.3%. It is evident that GF-109203X applied intracellularly removes the enhancing effect of BK on I 5-HT (Figure 4 ).
Discussion
The 5-HT-activated current we recorded from TG neu- Each point represents the mean±SEM of 7-9 neurons. This experiment was carried out using recording pipettes filled with CsCl containing internal solution.
rons was mediated by the 5-HT 3 receptor, the sole ligandgated ion channel (LGIC) in the family of 5-HT receptors, because it was blocked by ICS-205,930, a selective antagonist of the 5-HT 3 receptor ( Figure 1A ). There was evidence to indicate that 5-HT 3 receptors were present in rat TG neurons [23] . Similarly, B 2 BK receptors were also expressed in TG neurons [14] . In the present study we recorded both B 2 BK receptors and 5-HT 3 receptors in TG neurons, and in the majority of these neurons (89.2%, 66/74) the pre-application of BK (1×10 -7 mol/L) potentiated I 5-HT (1×10   -3 -1×10 -6 mol/L). This potentiation was mediated by B 2 BK receptors because the selective B 2 BK receptor antagonist Hoe 140 blocked this potentiating effect, obviously and reversibly (Figure 2 ). However, a previous study has reported that the inflammatory mediators BK, 5-HT, and prostaglandin E 2 do not cooperate to elevate intracellular calcium concentration when applied simultaneously for 10 s in cultured dorsal root ganglion neurons [24] . The distinction possibly results from different observation indices and specimens, or may be caused by the different treatment of BK. In the present experiment, there was also no enhancing effect observed when 5-HT and BK were co-applied for 3 s, whereas I 5-HT was potentiated by the pre-application of BK for more than 15 s ( Figure  1C) .
It is evident from Figure 1B that the enhancement of amplitude of I 5-HT increased gradually with incremental increases in the concentration of BK from 10 -10 to 10 -7 mol/L. However, when the concentration of BK increased to 10 -6 mol/L the modulatory effect of BK on I 5-HT did not increase further. The decrease in potentiation of I 5-HT by BK (10 -6 mol/L) might be a non-specific action of the agonist that emerges at high concentrations because very high concentrations of drug or ligand may block the channel and/or shelter the binding site of the receptor [25] . From the comparison between the concentration-response curves for 5-HT with and without the pre-application of BK ( Figure 3A ) it is clear that: (i) pre-application of BK shifted the curve upwards; (ii) the maximal response induced by 5-HT with BK pre-application increased by 68.9%, whereas the threshold concentrations of 5-HT in both cases were similar; and (iii) the EC 50 values of the two curves were very close (19.1±3.2 µmol/L vs 20.9±3.5 µmol/L). This implies that the intrinsic efficacy of the 5-HT 3 receptor increases after pretreatment with BK; however, its affinity does not change.
From the I-V curves for I 5-HT with and without BK pretreatment, it can be seen that the reverse potentials were the same (0 mV), indicating that there was no change in the ionic components mediating this current. This enhancement was not caused by the release of the channel blocker, as is the case in the voltage-dependent Mg 2+ block of NMDA-gated ion channel, because the BK-induced alteration of I 5-HT was not correlated with the change in holding potential ( Figure 3B ). This implies that the potentiation of I 5-HT by BK occurs in a voltage-independent manner.
The potentiation of I 5-HT by BK may involve intracellular signal transduction because there was no enhancing effect observed when 5-HT and BK were co-applied; nevertheless, BK applied prior to 5-HT application induced the enhancement of I 5-HT and this effect was positively related to the duration of BK pretreatment, implying that this enhancement is a time-consuming process. Furthermore, this potentiation was blocked by Hoe 140, a selective B 2 BK receptor antagonist. B 2 BK receptors belong to the superfamily of Gprotein-coupled receptors (GPCR) [20] . When activated by BK, the B 2 BK receptor is coupled to PLC β1 via G q/11 protein; which in turn catalyzes PIP 2 into secondary messengers, IP 3 and DAG. The latter activates PKC. Reports have shown that 5-HT 3 receptor function is enhanced by the activation of PKC [26, 27] . In the present experiment, the enhancing effect of BK on I 5-HT was evidently blocked by intracellular dialysis of GF-109203X, a selective PKC inhibitor [22] , indicating that potentiation occurs via a PKC-dependent pathway. How does PKC affect the function of 5-HT 3 receptors? Recently, a novel mechanism for 5-HT 3 receptor modulation by the activation of PKC was demonstrated [28] ; that is, the PKCinduced potentiation of 5-HT 3 receptor mediated current in Xenopus oocytes and mouse NIE-115 neuroblastoma cells resulted from the enhancement of F-actin-dependent trafficking of 5-HT 3 receptors instead of direct phosphorylation of the 5-HT 3A receptor protein.
What is the physiological significance of this BK modulation on I 5-HT or 5-HT 3 receptor function? In this work we used the cell body of TG neurons as a simple and accessible model to examine the characteristics of the membrane of peripheral terminals. The nerve endings of the peripheral axon of primary sensory neurons, including TG neurons, are sensitive to many inflammatory chemical mediators, of which BK and 5-HT are two potent stimulating mediators. In the case of inflammation and/or tissue damage these two substances are released. On the one hand, they exert a stimulating effect on the nerve endings and initiate nociceptive information through their corresponding receptors located on the membranes of separate nerve endings. On the other hand, in the present study we found that in the case of coexistence of B 2 BK receptors and 5-HT 3 receptors in TG neurons the inward current mediated by the 5-HT 3 receptor could be strengthened by pretreatment with BK, indicating that B 2 BK receptors and 5-HT 3 receptors may "cross-talk" in producing algesic information at nociceptors. Behavioral experiments have also demonstrated that 5-HT causes marked potentiation of BK-induced pain responses through 5-HT 3 receptors [29] . The present study may provide a hint for explaining the peripheral mechanism of pain and hyperalgesia caused by, for example, tissue damage and inflammation.
